Form 8-K · Current report
HP Inc. 8-K, filed Nov 4, 2026
- Filed
- CIK
- 0000047217
- Accession no.
- 0001140361-26-041969
Summary
HP Inc. appointed Emma Walmsley, formerly CEO of GSK, as its Chief Executive Officer effective January 4, 2027, with interim CEO Bruce Broussard stepping down from that role and becoming Chair of the Board, succeeding Chip Bergh, who continues on the board. Walmsley's offer includes a $1.45 million base salary, a $2.5 million sign-on bonus, a $30 million one-time inducement equity award, and relocation benefits of up to $2.5 million, and the board's authorized directorships will increase from 12 to 13 when she joins the board.
Key points
- Emma Walmsley will receive an annual base salary of $1,450,000 and a target bonus opportunity of 200% of base salary, prorated for fiscal 2027.
- The board approved a one-time inducement equity award of $30,000,000 for Walmsley in reliance on the NYSE employment inducement exemption to shareholder approval.
- Walmsley served as CEO of GSK from April 2017 to December 2025 and has been a Microsoft board member.
- The board adopted a bylaw amendment increasing authorized directorships from 12 to 13, effective January 4, 2027.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 4, 2026, HP Inc. (the “Company”) announced that the Board of Directors (the “Board”) of the Company appointed Emma Walmsley as Chief Executive Officer of the Company, effective as of January 4, 2027 (the “Start Date”). Bruce Broussard, the Company’s current Interim Chief Executive Officer, will step down from such role effective as of the end of the day on January 3, 2027. Effective as of the Start Date, Mr. Broussard will be appointed Chair of the Board and Ms. Walmsley will be appointed to the Board. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.